Skip to main content
Caplight Logo









Valthos

Valthos

Private
New York City, New YorkHealthcare & Life Scienceshttps://valthos.com/

Last Round

Early Stage

VC

Apr 1, 2026

Total Funding Raised

$30M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Valthos is a biotechnology and artificial intelligence company that develops software and AI systems to identify biological threats and design medical countermeasures.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Defense Tech, Drug Discovery, Medical AI, Threat Intelligence

Business Model

B2G

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

biodefensemedical countermeasure designbiological intelligencedefense techbiosecuritycomputational biologythreat intelligencedrug discoverymutational landscape analysisbio-surveillanceAI-driven softwarebiotech AIfrontier AIB2Gpandemic preparedness

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Valthos Comparables

Compare Valthos with similar companies based on industry and business-model similarity.

Valthos comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Radical Numerics
76%
Red Queen Bio
74%
Perimeter Systems
72%

Valthos Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCApr 1, 2026
SeedOct 29, 2025

Key People

Founding team and executive leadership

Kathleen McMahon

Co-Founder & CEO

Founding Team

Valthos Investors

Notable investors and investment history

Valthos investors
InvestorRounds
Founders FundSeed
Lux CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Grew 50% QoQ from 10 to 15 employees.

  • Jun 30, 2026

    Grew 25% QoQ from 12 to 15 employees.

Valthos Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Valthos Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Valthos's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range15
Year Founded2024
Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?